Sevin Turcan

Biomedical Engineering Tufts University, Boston 
"Sevin Turcan"
Mean distance: (not calculated yet)


Sign in to add mentor
Douglas E. Vetter grad student Tufts
 (Univ. Heidelberg)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Taranda J, Turcan S. (2021) 3D Whole-Brain Imaging Approaches to Study Brain Tumors. Cancers. 13
Turcan S, Makarov V, Taranda J, et al. (2017) Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence. Nature Genetics
Walsh LA, Roy DM, Reyngold M, et al. (2015) RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch. Oncogene. 34: 2189-203
Reyngold M, Turcan S, Giri D, et al. (2014) Remodeling of the methylation landscape in breast cancer metastasis. Plos One. 9: e103896
Gong Y, Zack TI, Morris LG, et al. (2014) Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins. Nature Genetics. 46: 588-94
Gerber NK, Goenka A, Turcan S, et al. (2014) Transcriptional diversity of long-term glioblastoma survivors. Neuro-Oncology. 16: 1186-95
Turcan S, Fabius AW, Borodovsky A, et al. (2013) Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine. Oncotarget. 4: 1729-36
Tönjes M, Barbus S, Park YJ, et al. (2013) BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nature Medicine. 19: 901-8
Ho AS, Kannan K, Roy DM, et al. (2013) The mutational landscape of adenoid cystic carcinoma. Nature Genetics. 45: 791-8
Rohle D, Popovici-Muller J, Palaskas N, et al. (2013) An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science (New York, N.Y.). 340: 626-30
See more...